File to download:
Title: First Results of the NeoALTTO Trial (BIG 01-06/EGF 106903): A Phase III, Randomized, Open-Label, Neoadjuvant Study of Lapatinib, Trastuzumab, and Their Combination Plus Paclitaxel in Women with HER2-Positive Primary Breast Cancer - PowerPoint PPT Presentation
Description: Dual blockage of HER2 is a valid ... from the study published by Dr Blackwell in the Journal of Clinical Oncology earlier ... Study Endpoints ... – PowerPoint PPT presentation
Download instruction:
The PPT version of this presentation was uploaded from an external web page or resource. We
cannot guarantee that the PPT file is still there nor can we verify that it is safe for you to
download. That said, if you whish to download it, please copy the URL below, and paste it into
the address bar of your browser.
PPT URL: http://www.researchtopractice.com/sites/default/files/5mjc/Browse-tumor-types/breast/5mjc_SABCS/2/ppt/5MJC-SABCS_1_Baselga_S3-3.ppt
